RecruitingPhase 1NCT07140016
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Studying Lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Astellas Pharma Global Development, Inc.
- Principal Investigator
- Medical MonitorAstellas Pharma Global Development, Inc.
- Intervention
- gilteritinib(drug)
- Enrollment
- 40 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2029
Study locations (15)
- University of California - Irvine, Orange, California, United States
- Emory Winship Cancer Institute, Atlanta, Georgia, United States
- OSF Health Care, Peoria, Illinois, United States
- University of Michigan Health Systems, Ann Arbor, Michigan, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- UT Southwestern Medical Center at Dallas, Dallas, Texas, United States
- Virginia Cancer Specialists PC, Fairfax, Virginia, United States
- Site FR33008, Saint-Herblain, France
- Site FR33005, Toulouse, France
- Site FR33001, Villejuif, France
- Site ES34017, Barcelona, Spain
- Site ES34006, Madrid, Spain
- Site ES34011, Madrid, Spain
- Site ES34008, Málaga, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07140016 on ClinicalTrials.govOther trials for Lymphoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07511426U96-CAR-T-Cells For R/R B-ALLThe First Affiliated Hospital of Soochow University
- RECRUITINGPHASE2NCT07316010Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell LymphomaM.D. Anderson Cancer Center
- RECRUITINGPHASE2NCT07372352Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCLThe First Affiliated Hospital of Soochow University
- RECRUITINGPHASE1, PHASE2NCT07575919Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALLLiping Dou
- ACTIVE NOT RECRUITINGPHASE1NCT07198087A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy ParticipantsOno Pharmaceutical Co. Ltd
- RECRUITINGNANCT07191431A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）Ruijin Hospital
- RECRUITINGPHASE1, PHASE2NCT07018752A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell LymphomasThe Lymphoma Academic Research Organisation
- RECRUITINGNANCT07058064WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)Mayo Clinic